One growth hormone molecule binds asymmetrically to two subunits of a dimeric GHR. A recent study, reported in 2005, suggested that inactive GHR dimers are already present on the cell surface ...

Fintel reports that on April 8, 2025, Goldman Sachs initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...

Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.

Promising new approach developed for overcoming treatment resistance in oestrogen receptor-positive (ER+) breast cancer ...

Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

"2025 is set to be a landmark year for Bayer Pharmaceuticals. We are bringing a number of groundbreaking products and our ...

Olema Pharmaceuticals palazestrant shows promise in late-stage trials for metastatic breast cancer with potential FDA ...

Unveiling how our bodies know what to eat Sponsored by Pennington Biomedical Research Center We know eating a balanced diet ...

Chronic pain affects millions of people, but if you're a woman, you're more likely to suffer. This reality has puzzled ...

North America Cancer Therapy Market Size Set Expands at Significant CAGR of 8.15% During 2024-2030 to Reach USD 5.87 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...